Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

ClinicalTrials.gov ID: NCT02932306

Public ClinicalTrials.gov record NCT02932306. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score \[EGSS\] of 3 \[moderate\] or 4 \[severe\]).

Study identification

NCT ID
NCT02932306
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
820 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 3, 2015 (Actual)
Primary completion
Feb 22, 2017 (Actual)
Completion
Feb 22, 2017 (Actual)
Last update posted
Jan 3, 2020

2015 – 2017

United States locations

U.S. sites
39
U.S. states
23
U.S. cities
37
Facility City State ZIP Site status
Valeant Site 36 Guntersville Alabama 35976 —
Valeant Site 14 Phoenix Arizona 85032 —
Valeant Site 28 Hot Springs Arkansas 71913 —
Valeant Site 38 Fountain Valley California 92708 —
Valeant Site 34 Manhattan Beach California 90266 —
Valeant Site 23 Oceanside California 92056 —
Valeant Site 35 Rancho Cucamonga California 91730 —
Valeant Site 20 San Diego California 92123 —
Valeant Site 32 Denver Colorado 80220 —
Valeant Site 10 Shelton Connecticut 06484 —
Valeant Site 02 Boynton Beach Florida 33437 —
Valeant Site 15 Coral Gables Florida 33146 —
Valeant Site 37 Miami Florida 33142 —
Valeant Site 39 Pembroke Pines Florida 33028 —
Valeant Site 01 West Palm Beach Florida 33401 —
Valeant Site 19 Boise Idaho 83704 —
Valeant Site 04 Arlington Heights Illinois 60005 —
Valeant Site 27 Carmel Indiana 46032 —
Valeant 12 Plainfield Indiana 46168 —
Valeant Site 09 Louisville Kentucky 40202 —
Valeant Site 16 Louisville Kentucky 40217 —
Valeant Site 33 Needham Massachusetts 02492 —
Valeant Site 11 Warren Michigan 48088 —
Valeant Site 08 Omaha Nebraska 68114 —
Valeant Site 25 Omaha Nebraska 68144 —
Valeant Site 13 Berlin New Jersey 08009 —
Valeant Site 03 Albuquerque New Mexico 87106 —
Valeant Site 26 New York New York 10022 —
Valeant Site 31 Stony Brook New York 11790 —
Valeant 05 Gresham Oregon 97030 —
Valeant Site 22 Fort Washington Pennsylvania 19034 —
Valeant Site 24 Charleston South Carolina 29414 —
Valeant Site 06 Dallas Texas 75231 —
Valeant Site 30 Houston Texas 77004 —
Valeant Site 17 Pflugerville Texas 78660 —
Valeant Site 07 San Antonio Texas 78229 —
Valeant 18 Webster Texas 77598 —
Valeant Site 29 Salt Lake City Utah 84117 —
Valeant Site 21 Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02932306, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2020 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02932306 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →